Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 16,929 | 20,161 | 11,897 | 11,233 | 4,010 |
| Operating Income | -16,929 | -20,161 | -11,897 | -11,233 | -4,010 |
| Other Income | 410 | 437 | 400 | 503 | 250 |
| Pre-tax Income | -16,519 | -19,724 | -11,497 | -10,730 | -3,760 |
| Net Income Continuous | -16,519 | -19,724 | -11,497 | -10,730 | -3,760 |
| Net Income | $-16,519 | $-19,724 | $-11,497 | $-10,730 | $-3,760 |
| EPS Basic Total Ops | -0.77 | 8.39 | -8.10 | -7.60 | -2.66 |
| EPS Basic Continuous Ops | -0.77 | 8.39 | -8.10 | -7.60 | -2.66 |
| EPS Diluted Total Ops | -0.77 | 8.39 | -8.10 | -7.60 | -2.66 |
| EPS Diluted Continuous Ops | -0.77 | 8.39 | -8.10 | -7.60 | -2.66 |
| EBITDA(a) | $-16,912 | $-20,148 | $-11,897 | $-11,233 | $-4,010 |